Here are four notes:
1. In the task force’s October 2015 draft guidelines, they recommended Cologuard as an “alternate” to other screening tests.
2. The task force clarified Cologuard’s standing in its final recommendation statement.
3. The task force acknowledges “there is no ‘one size fits all’ approach to colorectal cancer screening” and that it “seeks to provide clinicians and patients with the best possible evidence about the various screening methods to enable informed, individual decision making.”
4. The final recommendations also recognize the use of Cologuard every three years.
More articles on GI/endoscopy:
Lowcountry Gastroenterology Associates adds Dr. William Bulsiewicz — 5 points
Healthmark releases Now! test for ensuring endoscope safety: 3 points
Gastroenterologist to know: Dr. Christopher Forsmark of University of Florida
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
